Arizona Board of Regents; a Body Corporate of the State of Arizona; Acting for and on Behalf of Arizona State University
发明人:
Michael Sierks,Yong Shen
申请号：
US14370199
公开号：
US09512212B2
申请日:
2013.01.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to therapeutic agents comprising bispecific recombinant antibody fragments to selectively clear a protein associated with a neurological disease and methods of use of these therapeutic agents to treat neurological diseases.
